Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Lefamulin efficacy and safety in a pooled phase 3 clinical trial population with community-acquired bacterial pneumonia and common clinical comorbidities

Fig. 3

Subgroup analysis of a ECR in the pooled ITT population and IACR at TOC in the pooled b mITT and c CE populations. See Table 1 footnotes for subgroup definitions. ATS American Thoracic Society, CE clinically evaluable, COPD chronic obstructive pulmonary disease, ECR early clinical response, IACR investigator assessment of clinical response, ITT intent to treat, mITT modified ITT, PORT Pneumonia Outcomes Research Team, SIRS systemic inflammatory response syndrome

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us